Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (Q46493689)
Jump to navigation
Jump to search
scientific article published in May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer |
scientific article published in May 2005 |
Statements
1 reference
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (English)
1 reference
Teh-Ying Chou
1 reference
Chao-Hua Chiu
1 reference
Ling-Hui Li
1 reference
Chun-Yen Hsiao
1 reference
Chin-Yuan Tzen
1 reference
Kuo-Ting Chang
1 reference
Yuh-Min Chen
1 reference
Reury-Perng Perng
1 reference
Shih-Feng Tsai
1 reference
Chun-Ming Tsai
1 reference
1 May 2005
1 reference
11
1 reference
10
1 reference
3750-3757
1 reference